Boiron (XPAR:BOI) COGS-to-Revenue : 0.28 (As of Dec. 2023)

View and export this data going back to 1989. Start your Free Trial

What is Boiron COGS-to-Revenue?

Boiron's Cost of Goods Sold for the six months ended in Dec. 2023 was €70.2 Mil. Its Revenue for the six months ended in Dec. 2023 was €253.4 Mil.

Boiron's COGS to Revenue for the six months ended in Dec. 2023 was 0.28.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Boiron's Gross Margin % for the six months ended in Dec. 2023 was 72.29%.

Boiron COGS-to-Revenue Historical Data

The historical data trend for Boiron's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Boiron COGS-to-Revenue Chart

Boiron Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

COGS-to-Revenue

Get a 7-Day Free Trial

0.23

0.28

0.29

0.27

Boiron Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
COGS-to-Revenue	Get a 7-Day Free Trial															0.27	0.33	0.25	0.27	0.28

Boiron COGS-to-Revenue Calculation

Boiron's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	135.165	/	493.248
	=	0.27

Boiron's COGS to Revenue for the quarter that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	70.197	/	253.363
	=	0.28

Boiron (XPAR:BOI) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Boiron's Gross Margin % for the six months ended in Dec. 2023 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	70.197 / 253.363
	=	72.29 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Boiron COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Boiron's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Boiron (XPAR:BOI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Boiron SA (XPAR:BOI) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

BOIRF:USA BON:Germany

Address

2, Avenue de l’Ouest Lyonnais No. 039, Messimy, FRA, 69510

Website

http://www.boiron.com

Boiron is a drug manufacturer that focuses on homeopathic products. The company's revenue is roughly split between its nonproprietary homeopathic medicines and products in its over-the-counter specialties category. Boiron's nonproprietary medicines are generic products that do not refer to any therapeutic indication, while the specialties category includes first-resort products provided in tablet form, are bottled to use as drops, syrups, or ointments. Geographical segments are France, Europe, North America, and other countries. It generates a majority of revenue from France. The company's products include Oscillococcinum, Stodal and Stodaline, Arnigel, Camilia, Sedatif PC, Coryzalia, Homeoptic, and Homeovox.

Boiron (XPAR:BOI) Headlines

No Headlines